Bank of New York Mellon Corp Cuts Stock Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Bank of New York Mellon Corp reduced its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 1.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 284,614 shares of the company’s stock after selling 3,730 shares […]
Bank of New York Mellon Corp reduced its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 1.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 284,614 shares of the company’s stock after selling 3,730 shares […]
